Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

M.A. Davies, P. Saiag, C. Robert, J.-J. Grob, K.T. Flaherty, A. Arance, V. Chiarion-Sileni, L. Thomas, T. Lesimple, L. Mortier, S.J. Moschos, D. Hogg, I. Márquez-Rodas, M. Del Vecchio, C. Lebbé, N. Meyer, Y. Zhang, Y. Huang, B. Mookerjee, G.V. Long

Research output: Contribution to journalArticlepeer-review

Cite this